Activation of Human Peripheral Blood Mononuclear Cells by Nonpathogenic Bacteria In Vitro: Evidence of NK Cells as Primary Targets
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The interaction of commensal bacteria with immunocompetent cells may occur in definite compartments of the mucosal immune system, as limited translocation through the epithelial barrier cannot be excluded. In this study the stimulation of human peripheral blood mononuclear cells and purified lymphocyte subsets by nonpathogenic gram-positive lactobacilli (Lactobacillus johnsonii and Lactobacillus sakei) and gram-negative Escherichia coli was investigated. The various bacterial strains induced a differential cytokine pattern. Whereas L. johnsonii and L. sakei strongly induced gamma interferon (IFN-γ) and interleukin-12 (IL-12),E. coli and lipopolysaccharide (LPS) preferentially induced IL-10 after 16 h of stimulation. Expression of activation antigens CD69 and CD25 was observed on (CD3−CD56+) natural killer (NK) cells after stimulation of total human peripheral blood mononuclear cells. All bacteria mediated the proliferation of human peripheral blood mononuclear cells, and the strongest proliferative response was observed with L. johnsonii. Purified CD4+, CD8+, and CD19+lymphocyte subsets were not activated upon bacterial stimulation but showed normal response to a mitogenic stimulus. In contrast, purified NK cells upregulated the IL-2Rα chain (CD25) and underwent proliferation when stimulated by L. johnsonii. E. coli and LPS were less effective in inducing proliferation. Expression of CD25 or secretion of IFN-γ from purified NK cells was significantly increased in the presence of bacterially primed macrophages, indicating that full activation required both bacterium- and cell contact-based signals derived from accessory cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A medium for the cultivation of lactobacilli
De MAN, J. C., ROGOSA, M., & SHARPE, M. E. (1960) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1960.tb00188.x · Cited by 5,311 · cited 1×
“johnsonii La 1 (Nestlé strain collection) of human intestinal origin was cultivated in MRS broth (7) without acetate at 37°C.”
MethodThe prevalence of gut translocation in humans
Sedman, P. C., Macfle, J., Sagar, P., Mitchell, C. J., May, J., Mancey-Jones, B., & Johnstone, D. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90110-4 · Cited by 362 · cited 1×
“The occurrence of limited bacterial translocation to the lamina propria in humans has also been reported (6, 38).”
Background
Cited by
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., Barone, M., & Francavilla, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.578386 · Cited by 912
The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533
Pridmore, R. D., Berger, B., Desiere, F., Vilanova, D., Barretto, C., Pittet, A.-C., Zwahlen, M.-C., Rouvet, M., Altermann, E., Barrangou, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307327101 · Cited by 485
Probiotics: potential pharmaceutical applications
Kaur, I. P., Chopra, K., & Saini, A. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00209-3 · Cited by 392
Schultz, M., Veltkamp, C., Dieleman, L. A., Grenther, W. B., Wyrick, P. B., Tonkonogy, S. L., & Sartor, R. B. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200203000-00001 · Cited by 375
Bacterial direct-fed microbials in ruminant diets: Performance response and mode of action
Krehbiel, C. R., Rust, S. R., Zhang, G., & Gilliland, S. E. (2003) · Journal of Animal Science · doi:10.2527/2003.8114_suppl_2e120x · Cited by 356
A Special Fondness for Lactobacilli
Tannock, G. W. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.6.3189-3194.2004 · Cited by 325
Gill, H. S., Rutherfurd, K. J., & Cross, M. L. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1010979225018 · Cited by 304
Mulder, I. E., Schmidt, B., Stokes, C. R., Lewis, M., Bailey, M., Aminov, R. I., Prosser, J. I., Gill, B. P., Pluske, J. R., Mayer, C.-D., et al. (2009) · BMC Biology · doi:10.1186/1741-7007-7-79 · Cited by 294
Para-probiotics for Preterm Neonates—The Next Frontier
Deshpande, G., Athalye-Jape, G., & Patole, S. (2018) · Nutrients · doi:10.3390/nu10070871 · Cited by 164
da Silva, T. F., Glória, R. D. A., Americo, M. F., Freitas, A. D. S., de Jesus, L. C. L., Barroso, F. A. L., Laguna, J. G., Coelho-Rocha, N. D., Tavares, L. M., le Loir, Y., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10247-x · Cited by 117
“When human peripheral blood lymphocytes and PBMCs are exposed to LAB, they exhibit an increase in the production of interferon-gamma (IFN-g) by T and NK cells [160, 161].”
Probiotic viability–does it matter?
Lahtinen, S. J. (2012) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v23i0.18567 · Cited by 107
Yamano, T., Iino, H., Takada, M., Blum, S., Rochat, F., & Fukushima, Y. (2006) · British Journal of Nutrition · doi:10.1079/bjn20051507 · Cited by 98
“They activate natural killer cells (Haller et al. 2000 a ; Nagao et al. 2000), enhance IgA synthesis (Fukushima et al. 1998; Ibnou-Zekri et al. 2003), modulate cytokine production (Marin et al. 1997; Haller et al. 2000 b ) and contribute to the maintenance of body homeostasis (Hata et al. 1996;…”
InfluentialSelf-citationSCOTT, M. J., HOTH, J. J., STAGNER, M. K., GARDNER, S. A., PEYTON, J. C., & CHEADLE, W. G. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02547.x · Cited by 53
Metadata
- Authors
- Haller, D., Blum, S., Bode, C., Hammes, W. P., & Schiffrin, E. J.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2000-02
- Volume
- 68
- Issue
- 2
- Pages
- 752-759
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2160829089
- Cited by
- 187
- References
- 2
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.